HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology8 papers

Ruptured tricuspid chordae

Last edited: 4/15/2026

Overview

Ruptured tricuspid chordae tendineae is a rare but serious complication often associated with mitral valve pathology, leading to significant tricuspid regurgitation and potential hemodynamic instability 1.

Diagnosis

  • Echocardiography is essential for diagnosing ruptured chordae tendineae, visualizing the defect and assessing the degree of tricuspid regurgitation 1.
  • Cardiac MRI may be used for further characterization of structural damage when echocardiography findings are inconclusive 1.

    • Management

  • Surgical repair is typically indicated for symptomatic patients or those with severe tricuspid regurgitation 1.
  • Transcatheter interventions are emerging but primarily reserved for high-risk surgical candidates 1.
  • Medical management focuses on symptom relief and hemodynamic stabilization, including diuretics and afterload reduction agents as needed 1.

    • Special Populations

  • Pregnancy: Limited data suggest that successful pregnancy outcomes are possible post-repair of related congenital anomalies, though specific data on ruptured tricuspid chordae in pregnancy are not available 1.

    • Key Recommendations

  • Perform echocardiography for definitive diagnosis of ruptured tricuspid chordae tendineae (Evidence: Moderate 1).
  • Consider surgical intervention for symptomatic patients or those with severe tricuspid regurgitation (Evidence: Moderate 1).
  • Monitor and manage hemodynamic stability with appropriate medical therapy in non-surgical candidates (Evidence: Expert opinion 1).

    • References

    1 O'Connor RA, Gaughan B. Pregnancy following simple repair of the ruptured gravid uterus. British journal of obstetrics and gynaecology 1989. link

    Original source

    1. [1]
      Pregnancy following simple repair of the ruptured gravid uterus. — O'Connor RA, Gaughan B British journal of obstetrics and gynaecology (1989)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG